qfx

All the Horror Movies and Shows You Can Stream This Week at Home or Watch in Theaters, Including ‘The Hillside Strangler’

by

This week sees the release of ’28 Years Later: The Bone Temple,’ the latest film in the popular post-apocalyptic series. The movie picks up where the others left off, showing a world still struggling after a deadly virus outbreak. But the infected aren’t the only threat – survivors also face dangers from each other and the breakdown of society. The film explores how far people will go to survive and rebuild, and delivers the intense, fast-paced horror fans expect. It adds new layers to the story of the outbreak and introduces a fresh group of characters fighting for their lives as civilization crumbles.

The Biggest Box Office Flops by Stars

by

This science fiction movie, starring John Travolta, is based on a novel by L. Ron Hubbard. It’s about a future where humans fight back against an alien race called the Psychlos. When it was released in theaters, the film received a lot of criticism for its sets and the way the story was written. Ultimately, it didn’t make enough money in theaters to cover how much it cost to produce and advertise.

Erasca Insider Sells $671K as Stock Jumps 189%

by

Let’s break it down. They sold 120,000 shares, which is like throwing a party and everyone’s invited. The post-sale holdings? A mere 25,076 shares. That’s a drop from 145,076-like going from a full tank to a near-empty one. But hey, they still have 360,000 options left. So, maybe they’re just getting started. Or maybe they’re just hedging their bets. Who knows?

NYC Token Fanfare: A City of Coins and Ironies

by

Reports say the launch took place in Times Square, a stage fit for a sermon and a sales pitch at once, with Adams framing the token as a tool to support education and combat antisemitism and anti-American sentiment. The token rests on the Solana blockchain, as declared at launch, like an emblem pressed into the cold iron of the city. 🤖🗽

A Fund’s Bold Bet on a Stock in a Changing Market

by

The fund, Syquant Capital, moved quietly, like a man slipping into a crowded room. Their purchase, detailed in a filing with the SEC, was not a mere transaction but a statement. They had seen something in Chart Industries, a flicker of potential in a world where most things burn out quickly. The shares they took were not just numbers on a screen but a gamble on the future-a future that might not arrive.